Free Trial

Legal & General Group Plc Trims Stake in Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background

Legal & General Group Plc decreased its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 93.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,459 shares of the company's stock after selling 65,521 shares during the period. Legal & General Group Plc's holdings in Nu Skin Enterprises were worth $31,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Meeder Asset Management Inc. bought a new stake in Nu Skin Enterprises during the fourth quarter valued at about $25,000. US Bancorp DE lifted its holdings in Nu Skin Enterprises by 424.2% during the 4th quarter. US Bancorp DE now owns 7,460 shares of the company's stock worth $51,000 after buying an additional 6,037 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Nu Skin Enterprises by 536.8% in the 4th quarter. Signaturefd LLC now owns 8,087 shares of the company's stock valued at $56,000 after purchasing an additional 6,817 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Nu Skin Enterprises by 2,412.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company's stock worth $57,000 after acquiring an additional 7,888 shares during the period. Finally, Bank of Montreal Can acquired a new stake in shares of Nu Skin Enterprises during the fourth quarter worth $80,000. 82.84% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th.

Check Out Our Latest Stock Analysis on NUS

Nu Skin Enterprises Trading Down 0.9 %

Shares of NUS traded down $0.05 during mid-day trading on Wednesday, reaching $5.73. 684,128 shares of the company were exchanged, compared to its average volume of 837,732. The stock has a market capitalization of $284.86 million, a PE ratio of -1.94 and a beta of 0.92. The business has a 50 day simple moving average of $6.77 and a two-hundred day simple moving average of $6.93. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $14.00.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.14. The business had revenue of $445.55 million during the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. On average, analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were issued a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 4.19%. Nu Skin Enterprises's dividend payout ratio (DPR) is currently -8.14%.

About Nu Skin Enterprises

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines